↓ Skip to main content

First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, August 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
83 Mendeley
Title
First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Published in
European Journal of Nuclear Medicine and Molecular Imaging, August 2018
DOI 10.1007/s00259-018-4096-y
Pubmed ID
Authors

Jie Zang, Xinrong Fan, Hao Wang, Qingxing Liu, Jingnan Wang, Hui Li, Fang Li, Orit Jacobson, Gang Niu, Zhaohui Zhu, Xiaoyuan Chen

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 83 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 13%
Other 10 12%
Student > Master 10 12%
Student > Doctoral Student 7 8%
Student > Ph. D. Student 6 7%
Other 11 13%
Unknown 28 34%
Readers by discipline Count As %
Medicine and Dentistry 21 25%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Chemistry 4 5%
Biochemistry, Genetics and Molecular Biology 3 4%
Engineering 3 4%
Other 13 16%
Unknown 33 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2020.
All research outputs
#4,143,378
of 23,806,312 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#456
of 3,083 outputs
Outputs of similar age
#77,060
of 332,324 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#9
of 54 outputs
Altmetric has tracked 23,806,312 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,324 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.